Bone marrow fibrosis in chronic myelomonocytic leukemia is associated with increased megakaryopoiesis, splenomegaly and with a shorter median time to disease progression.
about
Bone marrow fibrosis in chronic myelomonocytic leukemia is associated with increased megakaryopoiesis, splenomegaly and with a shorter median time to disease progression.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Bone marrow fibrosis in chroni ...... n time to disease progression.
@en
Bone marrow fibrosis in chroni ...... n time to disease progression.
@nl
type
label
Bone marrow fibrosis in chroni ...... n time to disease progression.
@en
Bone marrow fibrosis in chroni ...... n time to disease progression.
@nl
prefLabel
Bone marrow fibrosis in chroni ...... n time to disease progression.
@en
Bone marrow fibrosis in chroni ...... n time to disease progression.
@nl
P2093
P2860
P50
P356
P1433
P1476
Bone marrow fibrosis in chroni ...... an time to disease progression
@en
P2093
Ahmet Dogan
April Chiu
Julia Geyer
Sharon Barouk-Fox
P2860
P304
103274-103282
P356
10.18632/ONCOTARGET.21870
P407
P577
2017-10-17T00:00:00Z